|
Name: 3-beta-hydroxy-estra-4,9,11-trien-17-one
Type: Estrogen derivative
AKA: N/A
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
3-Beta-Hydroxy-Estra-4,9,11-trien-17-One, a synthetic steroid, was first synthesized in the 1980s. It is a derivative of estrone with potential anabolic effects. The compound's development reflects ongoing research into steroids and their effects on muscle growth and performance. Regulatory measures have been implemented to manage its use.
|
|
V. Legal Information
3-Beta-Hydroxy-Estra-4,9,11-Trien-17-One is a steroidal compound with potential use in performance enhancement. It is regulated in many countries under anabolic steroid laws. In the U.S., it is classified under Schedule III of the Controlled Substances Act. Internationally, its legal status reflects concerns about misuse in sports and bodybuilding. [Source: UNODC].
US Federal Schedule - III
Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Some examples of Schedule III drugs are: products containing less than 90 milligrams of codeine per dosage unit (Tylenol with codeine), ketamine, anabolic steroids, testosterone.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
3-Beta-Hydroxy-Estra-4,9,11-Trien-17-One, also known as Norbolethone, is an anabolic steroid developed in the 1960s. It acts as an upper, promoting muscle growth and strength. Physical impacts include increased muscle mass and strength, but also elevated heart rate, hypertension, and potential liver damage. Short-term use can enhance physical performance, while long-term use may lead to hormonal imbalances and cardiovascular issues. Overdose risks include severe health complications. Safe use involves careful dosing and monitoring. Recent research examines its effectiveness and potential health risks.  |
|
VII. Psychological Effects
3-beta-Hydroxy-estra-4,9,11-trien-17-one, an androgenic steroid, affects mood and aggression. Immediate effects include increased energy and mood elevation. Long-term use can lead to mood swings, aggression, and cognitive impairments. Chronic use is associated with mood disorders and potential structural brain changes. Recent research emphasizes the psychological risks associated with anabolic steroids.
 |
|
VIII. Culture
3-Beta-Hydroxy-Estra-4,9,11-Trien-17-One is a synthetic steroid used in bodybuilding and performance enhancement. Its cultural significance reflects the broader anabolic steroid culture that has developed since the mid-20th century, particularly in competitive sports and bodybuilding. The substance is associated with debates over doping in sports and the health risks of steroid abuse. Media coverage often highlights both its effectiveness in muscle growth and the controversies surrounding its use. Proponents argue for its benefits in enhancing physical performance, while opponents raise concerns about health risks and ethical issues in sports. The substance is primarily used for performance enhancement rather than medicinal purposes.
 |